Delta-Fly Pharma, Inc. (4598) Dividends
Market cap
¥2.1B
P/E ratio
-1.2x
Delta-Fly Pharma develops cancer treatments using a unique "modular drug discovery" approach that builds new drugs from existing cancer-fighting compounds.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of Delta-Fly Pharma, Inc., the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>We determine dividends while prioritizing the accumulation of retained earnings to fund research and development investments. For the foreseeable future, we plan to retain all earnings without paying dividends, as we are making aggressive investments in pharmaceutical research and development. Should we decide to distribute dividends from retained earnings in the future, our basic policy is to pay dividends once annually at the fiscal year-end, though we also have the option to pay an interim dividend once per year if circumstances permit.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2025/05/15) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2025/05/15) | 0 | 0 | 0 | - |
| Forecast(2024/05/15) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2024/05/15) | 0 | 0 | 0 | - |
| Forecast(2023/05/15) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2023/05/15) | 0 | 0 | 0 | - |
| Forecast(2022/05/13) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2022/05/13) | 0 | 0 | 0 | - |
| Forecast(2021/05/14) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2021/05/14) | 0 | 0 | 0 | - |
| Forecast(2021/02/12) | 0 | 0 | 0 | - | |
| FY2020 | Actual(2021/02/12) | 0 | 0 | 0 | - |